Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > 100 Locations open tues in Ohio For Medical MJ $$$
View:
Post by 1hot-techwoman on Aug 05, 2024 4:59pm

100 Locations open tues in Ohio For Medical MJ $$$

BUSINESS

Recreational marijuana sales in Ohio can start Tuesday at nearly 100 locations

COLUMBUS, Ohio (AP) — Recreational marijuana sales will begin across Ohio on Tuesday when the state issues its first operating certificates.
Posted 11:18 a.m. Today - Updated 11:17 a.m. Today
 

COLUMBUS, Ohio (AP) — Recreational marijuana sales will begin across Ohio on Tuesday when the state issues its first operating certificates.

Nearly 100 medical marijuana dispensaries will be able to begin sales immediately, although it's not clear how many will be ready to open, the Division of Cannabis Control said Monday.

Many will be ready right away while others could be delayed by staffing or inventory issues.

The first round of operation certificates will go to 98 locations, according to the Division of Cannabis Control.

Ohio voters last November overwhelmingly approved allowing those over 21 to possess, purchase and grow limited amounts of cannabis for personal use. But recreational sales remained on hold while the state set up a regulated system for legal marijuana purchases and worked out other rules.

The new law allows adults 21 and over to buy and possess up to 2.5 ounces (70 grams) of cannabis and to grow up to six plants per individual or 12 plants per household at home.

Legal marijuana purchases will be subject to a 10% tax, with the revenue to be divided between administrative costs, addiction treatment, municipalities with dispensaries, and paying for social equity and jobs programs supporting the cannabis industry itself.

Comment by QContinuum1 on Aug 06, 2024 7:26am
Pointless and meaningless
Comment by alleyesonme on Aug 06, 2024 10:40am
Remidose's largest market is Ohio....I would think MPL would use this small but existing channel to bring other rec products.  Very relevant thanks.
Comment by QContinuum1 on Aug 06, 2024 12:31pm
Remidose's largest market = Rounding Error and is thus unimportant.  Might it become important in years to come, sure, but if LABS, via Stada say, couldn't crack Germany and Europe in the years since their 'exclusive' partnership, not sure the cannabis capital of Ohio moves the needle any time soon.
Comment by Starkicker on Aug 21, 2024 4:28pm
Came across this... Ohio has some serious sales numbers... https://mjbizdaily.com/ohio-marijuana-retailers-double-sales-after-adult-use-market-launch/
Comment by QContinuum1 on Aug 21, 2024 6:42pm
Keep in mind that LABS is not a market participant in Ohio save through the Remidose inhalers.  So while the market appears frothy, LABS is not benefitting from any of that.
Comment by Solid1 on Aug 22, 2024 6:28am
FDA approval is the only thing that matters - this was submitted in September 2023. Labs will benefit the most. It's been almost 12 months and a follow-up report could be coming soon 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities